Last reviewed · How we verify

NCT05012410

WeCareAdvisor Study for Caregivers of People Living With Dementia

Completed NA Last updated 30 September 2025
What this trial tests

NA trial testing Immediate treatment group with High-Intensity Prompts in Dementia in 262 participants. Completed in 19 July 2024.

Timeline
13 December 2021
Primary endpoint
19 July 2024
19 July 2024

Quick facts

Lead sponsorDrexel University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingsingle
Primary purposetreatment
Enrollment262
Start date13 December 2021
Primary completion19 July 2024
Estimated completion19 July 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Drexel University

Who can join

21 and older, any sex, with Dementia or Caregiver Burnout. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The WeCareAdvisor is an online tool to help caregivers manage behavioral and psychological symptoms of people living with dementia. The trial will evaluate its efficacy to reduce caregiver distress, improve confidence managing behaviors, as well as reduce occurrences and severity of behavioral and psychological symptoms. Visit https://wecareadvisorstudy.com/ for more information.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Dementia

Currently open trials in the same condition.

Other Drexel University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05012410.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing